Evidence map›Paper›PMID 42333651›Full record

ArticleActa paediatrica (Oslo, Norway : 1992)2026

Paediatric Healthcare Utilisation Trends From the Pre-Pandemic Period Through Two Years Post-COVID-19: Evidence From a Nationwide Big-Data Analysis.

Einat Shmueli, Elite Gutman, Joseph Levy, Maya Sagiv, Noam Wygoda, Hagit Levine, Patrick Stafler, Benjamin Rothschild, Meir Mei-Zahav, Dario Prais and 1 more

Abstract read
In one paragraph

Article in Acta paediatrica (Oslo, Norway : 1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Einat ShmueliPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Elite GutmanPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Joseph LevyResearch Data Center & Analytics, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Maya SagivResearch Data Center & Analytics, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Noam WygodaResearch Data Center & Analytics, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Hagit LevinePediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.ORCID https://orcid.org/0000-0001-6772-5784
Patrick StaflerPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Benjamin RothschildPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Meir Mei-ZahavPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Dario PraisPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Ophir Bar-OnPediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.ORCID https://orcid.org/0000-0001-7259-4539

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe COVID-19 pandemic was associated with a marked decline in respiratory infections and asthma exacerbations in children. Following the easing of restrictions, a rebound in respiratory morbidity was observed. However, the long-term impact on paediatric asthma remains unclear.

methodsWe conducted a retrospective study using data from the largest healthcare provider in Israel. Children aged 2-18 years with recurrent wheezing or clinician-diagnosed asthma were included. Healthcare utilisation between January 2019 and July 2023 was analysed.

resultsA total of 209 954 children, mean age 6.8 years (56.9% male), were included. During winter 2020-2021, compared with winter 2019-2020, healthcare utilisation declined significantly for chest radiographs (CXR) (RR = 0.69), asthma medication dispensing (RR = 0.67), and emergency department (ED) visits (RR = 0.61). After restrictions were lifted, all outcomes rose sharply, peaking in summer 2021. By winter 2022-2023, rates of CXR (RR = 1.30), asthma medication dispensing (RR = 1.03), ED visits (RR = 1.04), and hospitalisations (RR = 1.30) remained significantly higher than pre-pandemic levels across all age groups.

conclusionPaediatric respiratory-related healthcare utilisation exceeded pre-pandemic levels during the first and second post-pandemic winters. These findings highlight the unpredictable, long-lasting, and indirect consequences of pandemic-era interventions on respiratory health.

Indexed as

AsthmaCOVID-19Patient Acceptance of Health CareAdolescentChildChild, PreschoolEmergency Room VisitsEmergency Service, HospitalFemaleHumansIsraelMaleRetrospective StudiesCOVID‐19healthcare utilisationPaediatric asthmawheezing

Identifiers

PMID42333651
PMCPMC13552589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.